ApicHope Pharmaceutical (SHE:300723) subsidiary Guangzhou ApicHope will sign a clinical research commissioning contract with Boji Medical Technology (SHE:300404) for 6.5 million yuan, according to a Saturday disclosure to the Shenzhen Stock Exchange.
Boji will perform clinical research for the APH04935 tablets for weight management and obesity.
Shares rose 4% during afternoon trading on Monday.